Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

News | Cath Lab | August 26, 2015

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report...

C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
Feature | Drug-Eluting Balloons | July 08, 2015

July 8, 2015 - C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015,...

Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use
News | Drug-Eluting Balloons | June 11, 2015

June 11, 2015 - C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved...

IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR
News | May 22, 2015

May 22, 2015 — New clinical data from two different studies...

Stellarex, Spectranetics, investment, BTK, peripheral artery disease
News | May 06, 2015

May 6, 2015 — The Spectranetics Corporation announced it is accelerating investments in the Stellarex...

Videos | Drug-Eluting Balloons | April 02, 2015

In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease...

Videos | Cath Lab | March 25, 2015

Hear the latest trends and news on interventional cardiology from the American College of Cardiology (ACC) 2015...

Biotronik, Passeo-18 Lux, DCB, BIOLUX P-I, trial, drug eluting, balloon catheter
News | March 04, 2015

March 4, 2015 — Biotronik announced that results of its BIOLUX P-I...

In.PACT Admiral, PAD, Medicare, pass-through payment, Medtronic, balloon cath
News | February 23, 2015

February 23, 2015 — Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved...

Bard, Lutonix, drug coated balloon, DCB, CMS, pass-through payment, outpatient
News | February 23, 2015

February 23, 2015 — C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has...

Lutonix, drug eluting balloon, drug coated balloon

The Bard Lutonix drug-eluting balloon was the first DEB to gain FDA approval in October 2014. Illustration by Mike Austin. Copyright 2015. All Rights Reserved.

Feature | February 19, 2015 | Dave Fornell

Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new...

Boston Scientific, Bard, Lutonix, DCB, drug coated balloon, distribute
News | February 13, 2015

February 13, 2015 — Boston Scientific and C. R. Bard announced a deal where Boston Scientific will distribute the...

Medtronic, In.Pact Admiral DCB, PAD, U.S. launch, drug-coated balloon
News | February 06, 2015

February 6, 2015 — United States hospitals began using a new medical device from Medtronic plc  called the In.Pact...

drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath

The Bard Lutonix drug-eluting balloon was cleared by the FDA last November.

Feature | January 30, 2015

January 30, 2015 — ECRI Institute has created a report that offers an overview of...

News | January 09, 2015

January 9, 2015 — Covidien announced it has received CE Mark approval for its Stellarex...

Overlay Init